title: Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
authors.affiliation: Department of Metabolism, Endocrinology, Molecular Medicine and Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
authors.forename: Akinobu
authors.initials: A
authors.lastname: Ochi
authors.forename: Eiji
authors.initials: E
authors.lastname: Ishimura
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Ichii
authors.forename: Yoshiteru
authors.initials: Y
authors.lastname: Ohno
authors.forename: Shinya
authors.initials: S
authors.lastname: Nakatani
authors.forename: Ikue
authors.initials: I
authors.lastname: Kobayashi
authors.forename: Hideaki
authors.initials: H
authors.lastname: Shima
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tsuda
authors.forename: Kaori
authors.initials: K
authors.lastname: Shidara
authors.forename: Katsuhito
authors.initials: K
authors.lastname: Mori
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tamori
authors.forename: Masaaki
authors.initials: M
authors.lastname: Inaba
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000472:pathogenicity; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; C413685:entecavir; D006147:Guanine